MICHAEL ROONEY: Open Payments
NPI 1740835891 · KENNETT SQUARE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 14 payments from 7 companies in 2025. Trend: 2023 $52 · 2024 $0 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $143 |
| Organon LLC | 4 | $84 |
| UCB, Inc. | 3 | $73 |
| Incyte Corporation | 2 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: Kerecis SurgiClose, Bimzelx, OPZELURA, ILUMYA, TREMFYA, LIBTAYO.
Industry payments across PA — which companies pay providers there.
